In vitro pharmacoregulation of CC chemokine ligand 5 and its receptor CCR5 in diffuse lung diseases

In vitro pharmacoregulation of CC chemokine ligand 5 and its receptor CCR5 in diffuse lung diseases

Background: CC chemokine ligand (CCL)5 and its receptor CCR5 contribute to leukocyte migration into lungs of patients with diffuse lung diseases (DLD). Pharmacological regulation of CCL5 and CCR5 expression was therefore explored in bronchoalveolar cells obtained from patients with DLD.

Bibliographic Details
Main Authors: Veronika Sekerova, Daniela Subrtova, Frantisek Mrazek, Agata Gibejova, Vitezslav Kolek, Roland M. du Bois, Martin Petrek
Format: Article
Language:English
Published: Hindawi Limited 2003-01-01
Series:Mediators of Inflammation
Subjects:
Dexamethasone
Cyclosporin A
Pentoxifylline
Sarcoidosis
RANTES
Glucocorticoids
Bronchoalveolar cells.
Online Access:http://dx.doi.org/10.1080/09629350310001599657

Internet

http://dx.doi.org/10.1080/09629350310001599657

Similar Items